Hiroko Masamune work email
- Valid
- Valid
- Valid
- Valid
Hiroko Masamune personal email
Drug Development executive with extensive experience in taking late discovery assets through Phase 1 and Phase 2 clinical developmentStart up specialist providing scientific, strategic, and regulatory guidance, hands-on project management, and team leadershipSpecialties: Team leadership, scientific direction, and hands-on project management
Kissaki Biosciences, Inc.
-
Chief Executive OfficerKissaki Biosciences, Inc.San Diego, Ca, Us
-
Pharmaceutical Development ConsultantHiroko Masamune Consulting Aug 2019 - PresentStrategic consulting on CMC, PharmTox, DMPK, Bioanalytical, Regulatory affairs, and Discovery. Clients include numerous early stage / start up companies
-
Chief Development OfficerLassogen, Inc. Jun 2020 - Dec 2023San Diego, California, UsLassogen, Inc. is a preclinical biotechnology company formed to advance lasso peptides as a new modality to diagnose and treat disease. Key stakeholder in establishing strategic direction and corporate goals. Oversaw the external pharmacology and PK studies -
Chief Development OfficerViking Therapeutics, Inc. Jul 2018 - Jul 2019Primarily focussed on NASH.Responsible for CMC (drug substance and drug product), pharmacology, toxicology, DMPK, bioanalytical, regulatory affairs, and drug discovery
-
Svp, Pharmaceutical DevelopmentViking Therapeutics, Inc. Jun 2014 - Jun 2018Oversee discovery and non-clinical development pipeline for Viking's entire portfolio. Lead compound is a thyroid receptor beta agonist for NASH
-
Vp, Product DevelopmentAires Pharmaceuticals, Inc. Nov 2010 - Jan 2014Venture-backed start-up company (8 employees). Partnered with Novartis. Inhaled sodium nitrite for the treatment of Pulmonary Arterial Hypertension (orphan indication).Design and conduct of Phase 1 multiple dose studies in humans to establish the maximum tolerated dose. Characterization of the pharmacokinetic and pharmacodynamic interaction of inhaled sodium nitrite with a concomitantly administered oral therapeutic agent, and selection of the drug doses and the drug delivery device for a Phase II proof-of-concept (POC) study.Ongoing Phase 2 POC and OLE (open label extension) studies (40 sites, 14 countries, including several Eastern European countries, up to 90 subjects). Responsible for API synthesis, drug product manufacture (sterile liquid in glass vials and BFS ampules), drug delivery device selection and characterization, IV and inhalation chronic toxicology studies, multiple IND and IMPD amendments, bioanalytical assay development and sample analysis, supply chain for both drug product and device, inhalation device support to clinical trials (in lieu of specialty pharma CRO), substantial contributions to clinical protocols.
-
Vp, Product DevelopmentPalkion Inc. Jul 2008 - Mar 2011UsVenture-backed start-up company (3 employees), focused on late stage discovery and early drug development. Hypoxia Inducible Factor (HIF) - prolyl hydroxylase small molecule inhibitor for the treatment of anemia associated with chronic kidney disease. Responsibilities included API synthesis, drug product manufacture (oral capsule), toxicology and safety pharmacology studies, bioanalytical assay development and sample analysis, IND preparation, and contributions to clinical protocolNumerous presentations of scientific information to support financing efforts -
Senior Director, Pharmaceutical SciencesNeurogen Corporation Aug 2005 - May 2008UsSmall public “microcap” company (150 employees)Provided project management for all drug development teamsCreated a pharmaceutical sciences group (8 scientists)Developed oral controlled-release formulations for two Phase II compoundsDeveloped initial oral dose formulations for Phase I compoundsProvided analytical and formulation support for discovery-stage compounds -
Associate Project Manager, Senior Research InvestigatorPfizer, Inc. 1987 - 1999
Hiroko Masamune Skills
Hiroko Masamune Education Details
-
Massachusetts Institute Of TechnologyOrganic Chemistry -
UclaOrganic Chemistry -
University Of Wisconsin-MadisonChemistry
Frequently Asked Questions about Hiroko Masamune
What company does Hiroko Masamune work for?
Hiroko Masamune works for Kissaki Biosciences, Inc.
What is Hiroko Masamune's role at the current company?
Hiroko Masamune's current role is Chief Executive Officer.
What is Hiroko Masamune's email address?
Hiroko Masamune's email address is hi****@****zer.com
What schools did Hiroko Masamune attend?
Hiroko Masamune attended Massachusetts Institute Of Technology, Ucla, University Of Wisconsin-Madison.
What skills is Hiroko Masamune known for?
Hiroko Masamune has skills like Drug Development, Clinical Development, Biotechnology, Pharmaceutical Industry, R&d, Drug Discovery, Ind, Formulation, Product Development, Cro, Toxicology, Cmc.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial